Literature DB >> 21816272

Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons.

Liang Qiang1, Ryousuke Fujita, Toru Yamashita, Sergio Angulo, Herve Rhinn, David Rhee, Claudia Doege, Lily Chau, Laetitia Aubry, William B Vanti, Herman Moreno, Asa Abeliovich.   

Abstract

Directed conversion of mature human cells, as from fibroblasts to neurons, is of potential clinical utility for neurological disease modeling as well as cell therapeutics. Here, we describe the efficient generation of human-induced neuronal (hiN) cells from adult skin fibroblasts of unaffected individuals and Alzheimer's patients, using virally transduced transcription regulators and extrinsic support factors. hiN cells from unaffected individuals display morphological, electrophysiological, and gene expression profiles that typify glutamatergic forebrain neurons and are competent to integrate functionally into the rodent CNS. hiN cells from familial Alzheimer disease (FAD) patients with presenilin-1 or -2 mutations exhibit altered processing and localization of amyloid precursor protein (APP) and increased production of Aβ, relative to the source patient fibroblasts or hiN cells from unaffected individuals. Together, our findings demonstrate directed conversion of human fibroblasts to a neuronal phenotype and reveal cell type-selective pathology in hiN cells derived from FAD patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816272      PMCID: PMC3151530          DOI: 10.1016/j.cell.2011.07.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  28 in total

1.  The familial Parkinsonism gene LRRK2 regulates neurite process morphology.

Authors:  David MacLeod; Julia Dowman; Rachel Hammond; Thomas Leete; Keiichi Inoue; Asa Abeliovich
Journal:  Neuron       Date:  2006-11-22       Impact factor: 17.173

2.  Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.

Authors:  Emily S Walker; Maribel Martinez; Anne L Brunkan; Alison Goate
Journal:  J Neurochem       Date:  2005-01       Impact factor: 5.372

3.  Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.

Authors:  Mostafa Bentahir; Omar Nyabi; Jan Verhamme; Alexandra Tolia; Katrien Horré; Jens Wiltfang; Hermann Esselmann; Bart De Strooper
Journal:  J Neurochem       Date:  2006-01-09       Impact factor: 5.372

4.  In vitro-generated neural precursors participate in mammalian brain development.

Authors:  O Brüstle; A C Spiro; K Karram; K Choudhary; S Okabe; R D McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

Authors:  A M Cataldo; J L Barnett; C Pieroni; R A Nixon
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

Review 6.  Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease.

Authors:  Ralph A Nixon; Anne M Cataldo
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

7.  Expression of a single transfected cDNA converts fibroblasts to myoblasts.

Authors:  R L Davis; H Weintraub; A B Lassar
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

8.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

Review 9.  Amyloid precursor protein trafficking, processing, and function.

Authors:  Gopal Thinakaran; Edward H Koo
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

10.  Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease.

Authors:  A M Cataldo; D J Hamilton; J L Barnett; P A Paskevich; R A Nixon
Journal:  J Neurosci       Date:  1996-01       Impact factor: 6.167

View more
  125 in total

Review 1.  Cellular reprogramming: recent advances in modeling neurological diseases.

Authors:  Guo-Li Ming; Oliver Brüstle; Alysson Muotri; Lorenz Studer; Marius Wernig; Kimberly M Christian
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Induced neuronal cells: how to make and define a neuron.

Authors:  Nan Yang; Yi Han Ng; Zhiping P Pang; Thomas C Südhof; Marius Wernig
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

Review 3.  Stem cell therapy for cerebral ischemia: from basic science to clinical applications.

Authors:  Koji Abe; Toru Yamashita; Shunya Takizawa; Satoshi Kuroda; Hiroyuki Kinouchi; Nobutaka Kawahara
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

4.  Notable advances 2011.

Authors:  Michael Basson; Eva Chmielnicki; Kevin Da Silva; Alison Farrell; Randy Levinson; Juan Carlos López; Carolina Pola; Meera Swami
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

5.  Induced neural stem cells: a new tool for studying neural development and neurological disorders.

Authors:  Guang-Hui Liu; Fei Yi; Keiichiro Suzuki; Jing Qu; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2012-05-01       Impact factor: 25.617

Review 6.  A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine.

Authors:  Grace E Asuelime; Yanhong Shi
Journal:  J Mol Cell Biol       Date:  2012-02-27       Impact factor: 6.216

7.  Neurodegenerative disease: Dishing up Alzheimer's disease.

Authors:  Katherine Whalley
Journal:  Nat Rev Neurosci       Date:  2012-02-15       Impact factor: 34.870

8.  Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor.

Authors:  Karen L Ring; Leslie M Tong; Maureen E Balestra; Robyn Javier; Yaisa Andrews-Zwilling; Gang Li; David Walker; William R Zhang; Anatol C Kreitzer; Yadong Huang
Journal:  Cell Stem Cell       Date:  2012-06-07       Impact factor: 24.633

Review 9.  Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

Authors:  Sam Gandy; Steven T DeKosky
Journal:  Annu Rev Med       Date:  2013       Impact factor: 13.739

10.  Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation.

Authors:  Soham Chanda; Samuele Marro; Marius Wernig; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.